Literature DB >> 23987820

Interaction between myelomonocytic and lymphoid cells in a patient with acute myelomonocytic leukemia and chronic lymphocytic leukemia.

Paolo Strati1, John T Manning, Chi Young Ok, Guillermo Garcia-Manero, Zeev Estrov.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 23987820      PMCID： PMC4204466          DOI： 10.3109/10428194.2013.838234

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  10 in total

1.  Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo.

Authors:  Martina Seiffert; Angela Schulz; Sibylle Ohl; Hartmut Döhner; Stephan Stilgenbauer; Peter Lichter
Journal:  Blood       Date:  2010-07-26       Impact factor: 22.113

2.  The automated monocyte count is independently predictive of overall survival from diagnosis in chronic lymphocytic leukaemia and of survival following first-line chemotherapy.

Authors:  Ranjana Mazumdar; Paul Evans; Rachel Culpin; James Bailey; David Allsup
Journal:  Leuk Res       Date:  2013-03-20       Impact factor: 3.156

Review 3.  Occult B-cell lymphoproliferative disorders.

Authors:  Andy C Rawstron
Journal:  Histopathology       Date:  2011-01       Impact factor: 5.087

4.  Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1.

Authors:  S Huber; M Oelsner; T Decker; C Meyer zum Büschenfelde; M Wagner; G Lutzny; T Kuhnt; B Schmidt; R A J Oostendorp; C Peschel; I Ringshausen
Journal:  Leukemia       Date:  2011-02-04       Impact factor: 11.528

5.  Sorafenib-induced apoptosis of chronic lymphocytic leukemia cells is associated with downregulation of RAF and myeloid cell leukemia sequence 1 (Mcl-1).

Authors:  Jessie-F Fecteau; Ila S Bharati; Morgan O'Hayre; Tracy M Handel; Thomas J Kipps; Davorka Messmer
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

6.  Circulating microenvironment of CLL: are nurse-like cells related to tumor-associated macrophages?

Authors:  Agata A Filip; Bogumiła Ciseł; Dorota Koczkodaj; Ewa Wąsik-Szczepanek; Tomasz Piersiak; Anna Dmoszyńska
Journal:  Blood Cells Mol Dis       Date:  2013-01-11       Impact factor: 3.039

7.  Chronic myelomonocytic leukemia coexisting with B-cell chronic lymphocytic leukemia.

Authors:  Tadeusz Robak; Halina Urbańska-Ryś; Piotr Smolewski; Ewa Wawrzyniak; Anna Korycka; Radzisław Kordek; Jacek Bartkowiak
Journal:  Leuk Lymphoma       Date:  2003-11

Review 8.  Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signaling.

Authors:  Jan A Burger; Emili Montserrat
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

9.  Azacitidine in fludarabine-refractory chronic lymphocytic leukemia: a phase II study.

Authors:  Asifa Malik; Mahran Shoukier; Guillermo Garcia-Manero; William Wierda; Jorge Cortes; Susan Bickel; Michael J Keating; Zeev Estrov
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-12-21

10.  Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.

Authors:  John C Byrd; Richard R Furman; Steven E Coutre; Ian W Flinn; Jan A Burger; Kristie A Blum; Barbara Grant; Jeff P Sharman; Morton Coleman; William G Wierda; Jeffrey A Jones; Weiqiang Zhao; Nyla A Heerema; Amy J Johnson; Juthamas Sukbuntherng; Betty Y Chang; Fong Clow; Eric Hedrick; Joseph J Buggy; Danelle F James; Susan O'Brien
Journal:  N Engl J Med       Date:  2013-06-19       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.